The frequency and clinical significance of centromere enumeration probe 17 alterations in human epidermal growth factor receptor 2 immunohistochemistry‐equivocal invasive breast cancer

BACKGROUND AND AIMS: Chromosome 17 alterations affect the assessment of HER2 gene amplification in breast cancer (BC), but its clinical significance remains unclear. This study aimed to identify the prevalence of centromere enumeration probe 17 (CEP17) alterations, and its correlation with response...

Descripción completa

Detalles Bibliográficos
Autores principales: Katayama, Ayaka, Starczynski, Jane, Toss, Michael S, Shaaban, Abeer M, Provenzano, Elena, Quinn, Cecily M, Callagy, Grace, Purdie, Colin A, Millican‐Slater, Rebecca, Purnell, David, Chagla, Leena, Oyama, Tetsunari, Pinder, Sarah E, Chan, Steve, Ellis, Ian, Lee, Andrew H S, Rakha, Emad A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545957/
https://www.ncbi.nlm.nih.gov/pubmed/35879836
http://dx.doi.org/10.1111/his.14728

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545957/
https://www.ncbi.nlm.nih.gov/pubmed/35879836
http://dx.doi.org/10.1111/his.14728

Ejemplares similares